Company intelligence / Profile preview
Gador S.A.
- Ownership
- Private
- Employees
- ~1138
- Development stage
- Commercial
Overview
Gador has a large portfolio of pharmaceutical products for both primary care and specialty indications. The company develops its own medicines and also commercializes licensed products from major global pharma partners. It has invested in biopharmaceutics as a source of innovation and focuses on new-generation biosimilars and treatments for rare diseases. Its manufacturing plants are certified by international regulatory agencies (ANMAT, FDA, EMEA etc.), supporting exports to over 40 countries[2][5][6].
- Therapeutic areas
- OtherRare Diseases
- Modalities
- Small moleculesbiosimilarsbiopharmaceuticals
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Gador S.A..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gador S.A..